These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 19778496)

  • 1. Effectiveness of pharmacotherapy for severe personality disorders: meta-analyses of randomized controlled trials.
    Ingenhoven T; Lafay P; Rinne T; Passchier J; Duivenvoorden H
    J Clin Psychiatry; 2010 Jan; 71(1):14-25. PubMed ID: 19778496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effectiveness of antipsychotics in borderline personality disorder: meta-analyses of placebo-controlled, randomized clinical trials on symptomatic outcome domains.
    Ingenhoven TJ; Duivenvoorden HJ
    J Clin Psychopharmacol; 2011 Aug; 31(4):489-96. PubMed ID: 21694626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analyses of mood stabilizers, antidepressants and antipsychotics in the treatment of borderline personality disorder: effectiveness for depression and anger symptoms.
    Mercer D; Douglass AB; Links PS
    J Pers Disord; 2009 Apr; 23(2):156-74. PubMed ID: 19379093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacotherapy of borderline personality disorder: a systematic review for publication purpose.
    Bellino S; Rinaldi C; Bozzatello P; Bogetto F
    Curr Med Chem; 2011; 18(22):3322-9. PubMed ID: 21728970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsychotics, antidepressants, anticonvulsants, and placebo on the symptom dimensions of borderline personality disorder: a meta-analysis of randomized controlled and open-label trials.
    Vita A; De Peri L; Sacchetti E
    J Clin Psychopharmacol; 2011 Oct; 31(5):613-24. PubMed ID: 21869691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of pharmacotherapy against core traits of borderline personality disorder: meta-analysis of randomized controlled trials.
    Nosè M; Cipriani A; Biancosino B; Grassi L; Barbui C
    Int Clin Psychopharmacol; 2006 Nov; 21(6):345-53. PubMed ID: 17012981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of pharmacotherapies for borderline personality disorder.
    Bellino S; Paradiso E; Bogetto F
    CNS Drugs; 2008; 22(8):671-92. PubMed ID: 18601305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological interventions for people with borderline personality disorder.
    Binks CA; Fenton M; McCarthy L; Lee T; Adams CE; Duggan C
    Cochrane Database Syst Rev; 2006 Jan; (1):CD005653. PubMed ID: 16437535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychopharmacologic approaches to borderline syndromes.
    Ellison JM; Adler DA
    Compr Psychiatry; 1984; 25(3):255-62. PubMed ID: 6145542
    [No Abstract]   [Full Text] [Related]  

  • 10. Off-label use of atypical antipsychotics in personality disorders.
    Rosenbluth M; Sinyor M
    Expert Opin Pharmacother; 2012 Aug; 13(11):1575-85. PubMed ID: 21933032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological treatments for personality disorders.
    Paris J
    Int Rev Psychiatry; 2011 Jun; 23(3):303-9. PubMed ID: 21923229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy and acceptability of mood stabilizer and second generation antipsychotic monotherapy for acute mania--a systematic review and meta-analysis.
    Tarr GP; Glue P; Herbison P
    J Affect Disord; 2011 Nov; 134(1-3):14-9. PubMed ID: 21145595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review].
    Munch G; Godart N
    Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.
    Solmi M; Veronese N; Zaninotto L; van der Loos ML; Gao K; Schaffer A; Reis C; Normann C; Anghelescu IG; Correll CU
    CNS Spectr; 2016 Oct; 21(5):403-418. PubMed ID: 27686028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacotherapy effectiveness for some symptoms of borderline personality disorder].
    Benjaminsen S
    Ugeskr Laeger; 2014 Sep; 176(36):. PubMed ID: 25293847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lithium for maintenance treatment of mood disorders.
    Burgess S; Geddes J; Hawton K; Townsend E; Jamison K; Goodwin G
    Cochrane Database Syst Rev; 2001; (3):CD003013. PubMed ID: 11687035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapy for personality disorders.
    Hori A
    Psychiatry Clin Neurosci; 1998 Feb; 52(1):13-9. PubMed ID: 9682928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence.
    Sink KM; Holden KF; Yaffe K
    JAMA; 2005 Feb; 293(5):596-608. PubMed ID: 15687315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapist-supported Internet cognitive behavioural therapy for anxiety disorders in adults.
    Olthuis JV; Watt MC; Bailey K; Hayden JA; Stewart SH
    Cochrane Database Syst Rev; 2015 Mar; (3):CD011565. PubMed ID: 25742186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug therapy of patients with emotionally unstable personality].
    Nissen T
    Tidsskr Nor Laegeforen; 2000 Aug; 120(18):2135-41. PubMed ID: 11006733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.